@article{c333c1bd894c446da0968c64b1c361bb,
title = "Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab",
keywords = "Antibodies, Desensitization, Kidney transplant, Outcomes, Pathology, Rejection, Prognosis, Follow-Up Studies, Humans, Risk Factors, Rituximab, Antibodies, Monoclonal, Murine-Derived/administration \& dosage, Survival Rate, Transplantation, Homologous, Graft Rejection/drug therapy, Kidney Transplantation/adverse effects, Glomerulonephritis/etiology, Graft Survival/drug effects, Immunoglobulins, Intravenous/administration \& dosage, Kidney Diseases/complications, Inflammation/drug therapy, Retrospective Studies, Immunologic Factors/administration \& dosage",
author = "Joseph Kahwaji and Reiad Najjar and Deepika Kancherla and Rafael Villicana and Alice Peng and Stanley Jordan and Ashley Vo and Mark Haas",
note = "{\textcopyright} 2014 John Wiley \& Sons A/S. Published by John Wiley \& Sons Ltd.",
year = "2014",
month = may,
doi = "10.1111/ctr.12345",
language = "English",
volume = "28",
pages = "546--553",
journal = "Clinical Transplantation",
issn = "0902-0063",
number = "5",
}